 | • レポートコード：QYR9ST04725 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、バイオシミラー/生物学的製剤の世界市場について調査・分析し、バイオシミラー/生物学的製剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子、その他）、用途別（血液障害、がん疾患、慢性および自己免疫疾患、成長ホルモン欠乏症、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のバイオシミラー/生物学的製剤市場動向 ・主要企業別マーケットシェア ・バイオシミラー/生物学的製剤の種類別市場規模2014-2019 （ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子、その他） ・バイオシミラー/生物学的製剤の用途別市場規模2014-2019 （血液障害、がん疾患、慢性および自己免疫疾患、成長ホルモン欠乏症、その他） ・バイオシミラー/生物学的製剤の北米市場：主要企業・種類別/用途別市場規模 ・バイオシミラー/生物学的製剤のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・バイオシミラー/生物学的製剤の中国市場：主要企業・種類別/用途別市場規模 ・バイオシミラー/生物学的製剤の日本国内市場：主要企業・種類別/用途別市場規模 ・バイオシミラー/生物学的製剤の東南アジア市場：主要企業・種類別/用途別市場規模 ・バイオシミラー/生物学的製剤のインド市場：主要企業・種類別/用途別市場規模 ・バイオシミラー/生物学的製剤の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Novartis (Sandoz)、Synthon Pharmaceuticals、Teva Pharmaceutical Industries、LG Life Sciences、Celltrion Biocon、Hospira、Merck Serono (Merck)、Biogen idec、Genentech (Roche)） ・バイオシミラー/生物学的製剤の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Biosimilars or follow-on-biologics are the “copied” and licensed versions of those reference biologics that have undergone patent expiration. Biosimilars development and validation with reference biologics is a crucial aspect of the overall development process. In 2018, the global Biosimilars/follow-on-biologics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Biosimilars/follow-on-biologics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biosimilars/follow-on-biologics development in United States, Europe and China.
The key players covered in this study
Novartis (Sandoz)
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck Serono (Merck)
Biogen idec
Genentech (Roche)
Market segment by Type, the product can be split into
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
Market segment by Application, split into
Blood disorders
Oncology diseases
Chronic and autoimmune diseases
Growth hormone deficiencies
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Biosimilars/follow-on-biologics status, future forecast, growth opportunity, key market and key players.
To present the Biosimilars/follow-on-biologics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Biosimilars/follow-on-biologics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Biosimilars/follow-on-biologics Market Size Growth Rate by Type (2014-2025)
1.4.2 Human growth hormone
1.4.3 Erythropoietin
1.4.4 Monoclonal antibodies
1.4.5 Insulin
1.4.6 Interferon
1.4.7 Granulocyte-Colony Stimulating Factor
1.4.8 Others
1.5 Market by Application
1.5.1 Global Biosimilars/follow-on-biologics Market Share by Application (2014-2025)
1.5.2 Blood disorders
1.5.3 Oncology diseases
1.5.4 Chronic and autoimmune diseases
1.5.5 Growth hormone deficiencies
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Biosimilars/follow-on-biologics Market Size
2.2 Biosimilars/follow-on-biologics Growth Trends by Regions
2.2.1 Biosimilars/follow-on-biologics Market Size by Regions (2014-2025)
2.2.2 Biosimilars/follow-on-biologics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Biosimilars/follow-on-biologics Market Size by Manufacturers
3.1.1 Global Biosimilars/follow-on-biologics Revenue by Manufacturers (2014-2019)
3.1.2 Global Biosimilars/follow-on-biologics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Biosimilars/follow-on-biologics Market Concentration Ratio (CR5 and HHI)
3.2 Biosimilars/follow-on-biologics Key Players Head office and Area Served
3.3 Key Players Biosimilars/follow-on-biologics Product/Solution/Service
3.4 Date of Enter into Biosimilars/follow-on-biologics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Biosimilars/follow-on-biologics Market Size by Type (2014-2019)
4.2 Global Biosimilars/follow-on-biologics Market Size by Application (2014-2019)
5 United States
5.1 United States Biosimilars/follow-on-biologics Market Size (2014-2019)
5.2 Biosimilars/follow-on-biologics Key Players in United States
5.3 United States Biosimilars/follow-on-biologics Market Size by Type
5.4 United States Biosimilars/follow-on-biologics Market Size by Application
6 Europe
6.1 Europe Biosimilars/follow-on-biologics Market Size (2014-2019)
6.2 Biosimilars/follow-on-biologics Key Players in Europe
6.3 Europe Biosimilars/follow-on-biologics Market Size by Type
6.4 Europe Biosimilars/follow-on-biologics Market Size by Application
7 China
7.1 China Biosimilars/follow-on-biologics Market Size (2014-2019)
7.2 Biosimilars/follow-on-biologics Key Players in China
7.3 China Biosimilars/follow-on-biologics Market Size by Type
7.4 China Biosimilars/follow-on-biologics Market Size by Application
8 Japan
8.1 Japan Biosimilars/follow-on-biologics Market Size (2014-2019)
8.2 Biosimilars/follow-on-biologics Key Players in Japan
8.3 Japan Biosimilars/follow-on-biologics Market Size by Type
8.4 Japan Biosimilars/follow-on-biologics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Biosimilars/follow-on-biologics Market Size (2014-2019)
9.2 Biosimilars/follow-on-biologics Key Players in Southeast Asia
9.3 Southeast Asia Biosimilars/follow-on-biologics Market Size by Type
9.4 Southeast Asia Biosimilars/follow-on-biologics Market Size by Application
10 India
10.1 India Biosimilars/follow-on-biologics Market Size (2014-2019)
10.2 Biosimilars/follow-on-biologics Key Players in India
10.3 India Biosimilars/follow-on-biologics Market Size by Type
10.4 India Biosimilars/follow-on-biologics Market Size by Application
11 Central & South America
11.1 Central & South America Biosimilars/follow-on-biologics Market Size (2014-2019)
11.2 Biosimilars/follow-on-biologics Key Players in Central & South America
11.3 Central & South America Biosimilars/follow-on-biologics Market Size by Type
11.4 Central & South America Biosimilars/follow-on-biologics Market Size by Application
12 International Players Profiles
12.1 Novartis (Sandoz)
12.1.1 Novartis (Sandoz) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Biosimilars/follow-on-biologics Introduction
12.1.4 Novartis (Sandoz) Revenue in Biosimilars/follow-on-biologics Business (2014-2019)
12.1.5 Novartis (Sandoz) Recent Development
12.2 Synthon Pharmaceuticals
12.2.1 Synthon Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Biosimilars/follow-on-biologics Introduction
12.2.4 Synthon Pharmaceuticals Revenue in Biosimilars/follow-on-biologics Business (2014-2019)
12.2.5 Synthon Pharmaceuticals Recent Development
12.3 Teva Pharmaceutical Industries
12.3.1 Teva Pharmaceutical Industries Company Details
12.3.2 Company Description and Business Overview
12.3.3 Biosimilars/follow-on-biologics Introduction
12.3.4 Teva Pharmaceutical Industries Revenue in Biosimilars/follow-on-biologics Business (2014-2019)
12.3.5 Teva Pharmaceutical Industries Recent Development
12.4 LG Life Sciences
12.4.1 LG Life Sciences Company Details
12.4.2 Company Description and Business Overview
12.4.3 Biosimilars/follow-on-biologics Introduction
12.4.4 LG Life Sciences Revenue in Biosimilars/follow-on-biologics Business (2014-2019)
12.4.5 LG Life Sciences Recent Development
12.5 Celltrion Biocon
12.5.1 Celltrion Biocon Company Details
12.5.2 Company Description and Business Overview
12.5.3 Biosimilars/follow-on-biologics Introduction
12.5.4 Celltrion Biocon Revenue in Biosimilars/follow-on-biologics Business (2014-2019)
12.5.5 Celltrion Biocon Recent Development
12.6 Hospira
12.6.1 Hospira Company Details
12.6.2 Company Description and Business Overview
12.6.3 Biosimilars/follow-on-biologics Introduction
12.6.4 Hospira Revenue in Biosimilars/follow-on-biologics Business (2014-2019)
12.6.5 Hospira Recent Development
12.7 Merck Serono (Merck)
12.7.1 Merck Serono (Merck) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Biosimilars/follow-on-biologics Introduction
12.7.4 Merck Serono (Merck) Revenue in Biosimilars/follow-on-biologics Business (2014-2019)
12.7.5 Merck Serono (Merck) Recent Development
12.8 Biogen idec
12.8.1 Biogen idec Company Details
12.8.2 Company Description and Business Overview
12.8.3 Biosimilars/follow-on-biologics Introduction
12.8.4 Biogen idec Revenue in Biosimilars/follow-on-biologics Business (2014-2019)
12.8.5 Biogen idec Recent Development
12.9 Genentech (Roche)
12.9.1 Genentech (Roche) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Biosimilars/follow-on-biologics Introduction
12.9.4 Genentech (Roche) Revenue in Biosimilars/follow-on-biologics Business (2014-2019)
12.9.5 Genentech (Roche) Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Biosimilars/follow-on-biologics Key Market Segments
Table Key Players Biosimilars/follow-on-biologics Covered
Table Global Biosimilars/follow-on-biologics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Biosimilars/follow-on-biologics Market Size Market Share by Type 2014-2025
Figure Human growth hormone Figures
Table Key Players of Human growth hormone
Figure Erythropoietin Figures
Table Key Players of Erythropoietin
Figure Monoclonal antibodies Figures
Table Key Players of Monoclonal antibodies
Figure Insulin Figures
Table Key Players of Insulin
Figure Interferon Figures
Table Key Players of Interferon
Figure Granulocyte-Colony Stimulating Factor Figures
Table Key Players of Granulocyte-Colony Stimulating Factor
Figure Others Figures
Table Key Players of Others
Table Global Biosimilars/follow-on-biologics Market Size Growth by Application 2014-2025 (Million US$)
Figure Blood disorders Case Studies
Figure Oncology diseases Case Studies
Figure Chronic and autoimmune diseases Case Studies
Figure Growth hormone deficiencies Case Studies
Figure Others Case Studies
Figure Biosimilars/follow-on-biologics Report Years Considered
Table Global Biosimilars/follow-on-biologics Market Size 2014-2025 (Million US$)
Figure Global Biosimilars/follow-on-biologics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Biosimilars/follow-on-biologics Market Size by Regions 2014-2025 (Million US$)
Table Global Biosimilars/follow-on-biologics Market Size by Regions 2014-2019 (Million US$)
Table Global Biosimilars/follow-on-biologics Market Share by Regions 2014-2019
Figure Global Biosimilars/follow-on-biologics Market Share by Regions 2014-2019
Figure Global Biosimilars/follow-on-biologics Market Share by Regions 2019
Table Market Top Trends
Table Global Biosimilars/follow-on-biologics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Biosimilars/follow-on-biologics Market Share by Manufacturers (2014-2019)
Figure Global Biosimilars/follow-on-biologics Market Share by Manufacturers in 2018
Table Global Biosimilars/follow-on-biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Biosimilars/follow-on-biologics Product/Solution/Service
Table Date of Enter into Biosimilars/follow-on-biologics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Biosimilars/follow-on-biologics Market Size by Type (2014-2019) (Million US$)
Table Global Biosimilars/follow-on-biologics Market Size Share by Type (2014-2019)
Figure Global Biosimilars/follow-on-biologics Market Size Market Share by Type (2014-2019)
Table Global Biosimilars/follow-on-biologics Market Size by Application (2014-2019) (Million US$)
Table Global Biosimilars/follow-on-biologics Market Size Share by Application (2014-2019)
Figure Global Biosimilars/follow-on-biologics Market Size Market Share by Application (2014-2019)
Figure Global Biosimilars/follow-on-biologics Revenue Market Share by Application in 2018
Figure United States Biosimilars/follow-on-biologics Market Size 2014-2019 (Million US$)
Table United States Key Players Biosimilars/follow-on-biologics Revenue (2018-2019) (Million US$)
Table United States Key Players Biosimilars/follow-on-biologics Market Share (2018-2019)
Table United States Biosimilars/follow-on-biologics Market Size by Type (2014-2019) (Million US$)
Table United States Biosimilars/follow-on-biologics Market Share by Type (2014-2019)
Table United States Biosimilars/follow-on-biologics Market Size by Application (2014-2019) (Million US$)
Table United States Biosimilars/follow-on-biologics Market Share by Application (2014-2019)
Figure Europe Biosimilars/follow-on-biologics Market Size 2014-2019 (Million US$)
Table Europe Key Players Biosimilars/follow-on-biologics Revenue (2018-2019) (Million US$)
Table Europe Key Players Biosimilars/follow-on-biologics Market Share (2018-2019)
Table Europe Biosimilars/follow-on-biologics Market Size by Type (2014-2019) (Million US$)
Table Europe Biosimilars/follow-on-biologics Market Share by Type (2014-2019)
Table Europe Biosimilars/follow-on-biologics Market Size by Application (2014-2019) (Million US$)
Table Europe Biosimilars/follow-on-biologics Market Share by Application (2014-2019)
Figure China Biosimilars/follow-on-biologics Market Size 2014-2019 (Million US$)
Table China Key Players Biosimilars/follow-on-biologics Revenue (2018-2019) (Million US$)
Table China Key Players Biosimilars/follow-on-biologics Market Share (2018-2019)
Table China Biosimilars/follow-on-biologics Market Size by Type (2014-20189) (Million US$)
Table China Biosimilars/follow-on-biologics Market Share by Type (2014-2019)
Table China Biosimilars/follow-on-biologics Market Size by Application (2014-2019) (Million US$)
Table China Biosimilars/follow-on-biologics Market Share by Application (2014-2019)
Figure Japan Biosimilars/follow-on-biologics Market Size 2014-2019 (Million US$)
Table Japan Key Players Biosimilars/follow-on-biologics Revenue (2018-2019) (Million US$)
Table Japan Key Players Biosimilars/follow-on-biologics Market Share (2018-2019)
Table Japan Biosimilars/follow-on-biologics Market Size by Type (2014-2019) (Million US$)
Table Japan Biosimilars/follow-on-biologics Market Share by Type (2014-2019)
Table Japan Biosimilars/follow-on-biologics Market Size by Application (2014-2019) (Million US$)
Table Japan Biosimilars/follow-on-biologics Market Share by Application (2014-2019)
Figure Southeast Asia Biosimilars/follow-on-biologics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Biosimilars/follow-on-biologics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Biosimilars/follow-on-biologics Market Share (2018-2019)
Table Southeast Asia Biosimilars/follow-on-biologics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Biosimilars/follow-on-biologics Market Share by Type (2014-2019)
Table Southeast Asia Biosimilars/follow-on-biologics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Biosimilars/follow-on-biologics Market Share by Application (2014-2019)
Figure India Biosimilars/follow-on-biologics Market Size 2014-2019 (Million US$)
Table India Key Players Biosimilars/follow-on-biologics Revenue (2018-2019) (Million US$)
Table India Key Players Biosimilars/follow-on-biologics Market Share (2018-2019)
Table India Biosimilars/follow-on-biologics Market Size by Type (2014-2019) (Million US$)
Table India Biosimilars/follow-on-biologics Market Share by Type (2014-2019)
Table India Biosimilars/follow-on-biologics Market Size by Application (2014-2019) (Million US$)
Table India Biosimilars/follow-on-biologics Market Share by Application (2014-2019)
Figure Central & South America Biosimilars/follow-on-biologics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Biosimilars/follow-on-biologics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Biosimilars/follow-on-biologics Market Share (2018-2019)
Table Central & South America Biosimilars/follow-on-biologics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Biosimilars/follow-on-biologics Market Share by Type (2014-2019)
Table Central & South America Biosimilars/follow-on-biologics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Biosimilars/follow-on-biologics Market Share by Application (2014-2019)
Table Novartis (Sandoz) Company Details
Table Novartis (Sandoz) Revenue in Biosimilars/follow-on-biologics Business (2014-2019) (Million US$)
Figure Novartis (Sandoz) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2014-2019)
Table Novartis (Sandoz) Recent Development
Table Synthon Pharmaceuticals Company Details
Table Synthon Pharmaceuticals Revenue in Biosimilars/follow-on-biologics Business (2014-2019)(Million US$)
Figure Synthon Pharmaceuticals Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2014-2019)
Table Synthon Pharmaceuticals Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Revenue in Biosimilars/follow-on-biologics Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Industries Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2014-2019)
Table Teva Pharmaceutical Industries Recent Development
Table LG Life Sciences Company Details
Table LG Life Sciences Revenue in Biosimilars/follow-on-biologics Business (2014-2019)(Million US$)
Figure LG Life Sciences Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2014-2019)
Table LG Life Sciences Recent Development
Table Celltrion Biocon Company Details
Table Celltrion Biocon Revenue in Biosimilars/follow-on-biologics Business (2014-2019)(Million US$)
Figure Celltrion Biocon Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2014-2019)
Table Celltrion Biocon Recent Development
Table Hospira Company Details
Table Hospira Revenue in Biosimilars/follow-on-biologics Business (2014-2019)(Million US$)
Figure Hospira Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2014-2019)
Table Hospira Recent Development
Table Merck Serono (Merck) Company Details
Table Merck Serono (Merck) Revenue in Biosimilars/follow-on-biologics Business (2014-2019)(Million US$)
Figure Merck Serono (Merck) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2014-2019)
Table Merck Serono (Merck) Recent Development
Table Biogen idec Company Details
Table Biogen idec Revenue in Biosimilars/follow-on-biologics Business (2014-2019)(Million US$)
Figure Biogen idec Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2014-2019)
Table Biogen idec Recent Development
Table Genentech (Roche) Company Details
Table Genentech (Roche) Revenue in Biosimilars/follow-on-biologics Business (2014-2019)(Million US$)
Figure Genentech (Roche) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2014-2019)
Table Genentech (Roche) Recent Development
Table Global Biosimilars/follow-on-biologics Market Size by Regions (Million US$) 2019-2025
Figure Global Biosimilars/follow-on-biologics Market Size Share by Regions (2019-2025)
Figure Global Biosimilars/follow-on-biologics Market Size Share by Regions in 2025
Figure United States Biosimilars/follow-on-biologics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Biosimilars/follow-on-biologics Market Size Forecast (2019-2025)(Million USD)
Figure China Biosimilars/follow-on-biologics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Biosimilars/follow-on-biologics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Biosimilars/follow-on-biologics Market Size Forecast (2019-2025)(Million USD)
Figure India Biosimilars/follow-on-biologics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Biosimilars/follow-on-biologics Market Size Forecast (2019-2025)(Million USD)
Table Global Biosimilars/follow-on-biologics Market Size by Product (2019-2025) (Million US$)
Figure Global Biosimilars/follow-on-biologics Market Size by Product (2019-2025)
Figure Global Biosimilars/follow-on-biologics Market Size by Product in 2025
Table Global Biosimilars/follow-on-biologics Market Size by Application (2019-2025) (Million US$)
Figure Global Biosimilars/follow-on-biologics Market Size by Application (2019-2025)
Figure Global Biosimilars/follow-on-biologics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
G-CSFバイオシミラーの世界市場：インサイト・予測 Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are…- コロニーカウンターシステムの世界市場：市場規模・現状・予測 Biological procedures often rely on an accurate count of bacterial colonies and cells. Colony counters are used to estimate a liquid culture’s density of microorganisms by counting individual colonies on an agar plate, slide, mini gel, or Petri dish.In 2018, the global Colony Counter System market s…
- コロニーカウンターシステムの世界市場：市場規模・現状・予測 Biological procedures often rely on an accurate count of bacterial colonies and cells. Colony counters are used to estimate a liquid culture’s density of microorganisms by counting individual colonies on an agar plate, slide, mini gel, or Petri dish.In 2018, the global Colony Counter System market s…
- 生物製剤アウトソーシングの世界市場：市場規模・現状・予測 Outsourcing is increasing as a percentage of the whole manufacturing capacity due to relatively more of new product manufacturing is outsourced and facilities with products that become generic are non-core and are being divested.In 2018, the global Biologics Outsourcing market size was xx million US…
- 次世代生物製剤の世界市場：市場規模・現状・予測 Next generation biologics refers to some noval drugs, biotreatment and some breakthroght biomaterials etc.The increasing demand for antibody drug conjugates (ADCs) is one of the major factors driving this market’s growth. ADCs are highly effective cytotoxic drugs linked to an mAbs. These drugs have …